Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 3, 2007 - Issue 2
Submit an article Journal homepage
1,255
Views
81
CrossRef citations to date
0
Altmetric
Review

Amino acid conjugation: contribution to the metabolism and toxicity of xenobiotic carboxylic acids

Kathleen M Knights Associate Professor, Flinders University & Flinders Medical Center, Department of Clinical Pharmacology, Bedford Park, Adelaide 5042, Australia. [email protected]
,
Matthew J Sykes Research Fellow, Flinders University & Flinders Medical Center, Department of Clinical Pharmacology, Bedford Park, Adelaide 5042, Australia. [email protected]
&
John O Miners Professor and Head, Department of Clinical Pharmacology, Flinders University & Flinders Medical Centre, Bedford Park, Adelaide 5042, Australia. [email protected]
Pages 159-168 | Published online: 11 Apr 2007

Bibliography

  • URE A: On gouty concretions; with a new method of treatment. Pharm. J. Transact. (1841) 1:24.
  • DESSAIGNES V: Nouvelles recherches sur l’acide hippurique, l’acide benzoique et le sucre de gelatine. Compte Rendu de l’Academie des Sciences (Paris) (1845) 21:1224-1227.
  • VESSEY DA, KELLEY M: Characterization of the reaction mechanism for the XL-1 form of bovine liver xenobiotic/medium-chain fatty acid:CoA ligase. Biochem. J. (2001) 357:283-288.
  • MAHLER HR, WAKIL SJ, BOCK RM: Studies on fatty acid oxidation 1. Enzymatic activation of fatty acids. J. Biol. Chem. (1953) 204:453-468.
  • KILLENBERG PG, DAVIDSON ED, WEBSTER LT: Evidence for a medium-chain fatty acid:coenzyme A ligase (adenosine monophosphate) that activates salicylate. Mol. Pharmacol. (1971) 7:260-268.
  • GROOT PHE, SCHOLTE HR, HULSMANN WC: Fatty acid activation: Specificity, localization, and function. Adv. Lipid Res. (1976) 14:75-126.
  • GROOT PH: Acyl-CoA synthetases in guinea-pig liver mitochondria: purification and characterization of a distinct propionyl-CoA synthetase. Biochem. Biophys. Acta. (1976) 441:260-267.
  • VESSEY DA, HU J: Isolation from bovine liver mitochondria and characterization of three distinct carboxylic acid:CoA ligases with activity toward xenobiotics. J. Biochem. Toxicol. (1995) 10:329-337.
  • VESSEY DA, KELLEY M: Purification and partial sequencing of the XL-I form of xenobiotic-metabolizing medium chain fatty acid:CoA ligase from bovine liver mitochondria, and its homology with the essential hypertension protein. Biochim. Biophys. Acta (1997) 1346:231-236.
  • VESSEY DA, LAU E, KELLEY M: Isolation and sequencing of cDNAs for the XL-1 and XL-III forms of bovine liver xenobiotic-metabolizing medium-chain fatty acid:CoA ligase. J. Biochem. Mol. Toxicol. (2000) 14:11-19.
  • KASUYA F, IGARASHI K, FUKUI M, NOKIHARA K: Purification and characterization of a medium chain acyl-coenzyme A synthetase. Drug Metab. Dispos. (1996) 24:879-883.
  • VESSEY DA, KELLEY M, WARREN RS: Characterization of the CoA ligases of human liver mitochondria catalyzing the activation of short- and medium-chain fatty acids and xenobiotic carboxylic acids. Biochim. Biophys. Acta (1999) 1428:455-462.
  • VESSEY DA, LAU E, KELLEY M, WARREN RS: Isolation, sequencing, and expression of a cDNA for the HXM-A form of xenobiotic/medium-chain fatty acid:CoA ligase from human liver mitochondria. J. Biochem. Mol. Toxicol. (2003) 17:1-6.
  • VESSEY DA, KELLEY M, LAU E: Development of a radiolabeled ATP assay for carboxylic acid:CoA ligases and its use in the characterization of the xenobiotic carboxylic acid:CoA ligases of bovine liver mitochondria. J. Biochem. Mol. Toxicol. (1998) 12:151-155.
  • KASUYA F, IGARASHI K, FUKUI M: Participation of a medium chain acyl-CoA synthetase in glycine conjugation of the benzoic acid derivatives with the electron-donating groups. Biochem. Pharmacol. (1996) 51:805-809.
  • KASUYA F, YAMAOKA Y, IGARASHI K, FUKUI M: Molecular specificity of a medium chain acyl-CoA synthetase for substrates and inhibitors. Biochem. Pharmacol. (1998) 55:1769-1775.
  • VESSEY DA, HU J, KELLEY M: Interaction of salicylate and ibuprofen with the carboxylic acid:CoA ligases from bovine liver mitochondria. J. Biochem. Toxicol. (1996) 11:73-78.
  • MINERS JO, GRGURINOVICH N, WHITEHEAD AG, ROBSON RA, BIRKETT DJ: Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acid. Br. J. Clin. Pharmacol. (1986) 22:135-142.
  • SHERRATT HAS: Hypoglycin, the famous toxin of the unripe Jamaican ackee fruit. Trends Pharmacol. Sci. (1986) 7:186-191.
  • RUFF LJ, BRASS EP: Metabolic effects of pivalate in isolated rat hepatocytes. Toxicol. App. Pharmacol. (1991) 110:295-302.
  • KIORPES TC, HOERR D, HO W, WEANER LE, INMAN MG, TUTWILER GF: Identification of 2-tetradecylglycidyl coenzyme A as the active form of methyl 2-tetradecylglycidate (methyl palmoxirate) and its characterization as an irreversible, active site-directed inhibitor of carnitine palmitoyltransferase A in isolated rat liver mitochondria. J. Biol. Chem. (1984) 259:9750-9755.
  • CUEBAS D, BECKMANN JD, FRERMAN FE, SCHULZ H: Mitochondrial metabolism of 3-mercaptopropionic acid: Chemical synthesis of 3-mercaptopropionyl coenzyme A and some of its S-acyl derivatives. J. Biol. Chem. (1985) 260:7330-7336.
  • OLSEN J, LI C, BJORNSDOTTIR I, SIDENIUS U, HANSEN SH, BENET LZ: In vitro and in vivo studies on acyl-coenzyme A-dependent bioactivation of zomepirac in rats. Chem. Res. Toxicol. (2005) 18:1729-1736.
  • MEULDERMANS W, HENDRICKX J, LAUWERS W, HURKMANS R, SWYSEN E, HEYKANTS J: Excretion and biotransformation of astemizole in rats, guinea-pigs, dogs, and man. Drug Devel. Res. (1986) 8:37-51.
  • SUH OK, KIM SH, LEE MG: Pharmacokinetics and pharmacodynamics of azosemide. Biopharm. Drug Dispos. (2003) 24:275-297.
  • BRUCE RB, TURNBULL LB, NEWMAN JH, PITTS JE: Metabolism of brompheniramine. J. Med. Chem. (1968) 11:1031-1034.
  • NUTLEY BP, FARMER P, CALDWELL J: Metabolism of trans-cinnamic acid in the rat and the mouse and its variation with dose. Food Chem. Toxicol. (1994) 32:877-886.
  • VAN RAVENZWAAY B, PIGOTT G, LEIBOLD E: Absorption, distribution, metabolism and excretion of 4-chloro-2-methylphenoxyacetic acid (MCPA) in rats. Food Chem. Toxicol. (2004) 42:115-125.
  • AHN KC, MA S-J, TSAI H-J, GEE SJ, HAMMOCK BD: An immunoassay for a urinary metabolite as a biomarker of human exposure to the pyrethroid insecticide permethrin. Anal. Bioanal. Chem. (2006) 384:713-722.
  • MURDOCH D, PLOSKER GL: Triflusal a review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillation. Drugs (2006) 66:671-692.
  • CAMPBELL L, WILSON HK, SAMUEL AM, GOMPERTZ D: Interactions of m-xylene and aspirin metabolism in man. Br. J. Ind. Med. (1988) 45:127-132.
  • SCHACHTER D, TAGGART JV: Benzoyl coenzyme A and hippurate synthesis. J. Biol. Chem. (1953) 203:925-934.
  • WEBSTER LT, SIDDIQUI UA, LUCAS SV, STRONG JM, MIEYAL JJ: Identification of separate acyl-CoA:glycine and acyl-CoA:L-glutamine N-acyltransferase activities in mitochondrial fractions from liver of rhesus monkey and man. J. Biol. Chem. (1976) 251:3352-3358.
  • MAWAL YR, QURESHI IA: Purification to homogeneity of mitochondrial acyl CoA:glycine N-acyltransferase from human liver. Biochem. Biophys. Res. Comm. (1994) 205:1373-1379.
  • KELLEY M, VESSEY DA: Characterization of the acyl-CoA: amino acid N-acyltransferases from primate liver mitochondria. J. Biochem. Toxicol. (1994) 9:153-158.
  • ANDI DL, LUCAS SV, WEBSTER LT: Benzoyl-coenzyme A:glycine N-acyltransferase and phenylacetyl-coenzyme A:glycine N-acyltransferase from bovine liver mitochondria. J. Biol. Chem. (1979) 254:7230-7237.
  • KELLEY M, VESSEY DA: Interaction of 2,4-dichlorophenoxyacetate (2,4-D) and 2,4,5-trichlorophenoxyacetate (2,4,5-T) with the acyl-CoA:amino acid N-acyltransferase enzymes of bovine liver mitochondria. Biochem. Pharmacol. (1986) 35:289-295.
  • HUTT AJ, CALDWELL J: Amino acid conjugation. In: Conjugation reactions in drug metabolism. Mulder GJ (Ed.), Taylor & Francis, London, UK (1990):273-305.
  • GREGUS Z, FEKETE T, VARGA F, KLAASSEN CD: Dependence of glycine conjugation on the availability of glycine: the role of the glycine cleavage system. Xenobiotica (1993) 23:141-154.
  • GREGUS Z, FEKETE T, HALASZI E, GYURASICS A, KLAASSEN CD: Effects of fibrates on the glycine conjugation of benzoic acid in rats. Drug Metab. Dispos. (1998) 26:1082-1088.
  • LEVY G: Salicylurate formation – demonstration of Michaelis–Menten kinetics in man. J. Pharm. Sci. (1965) 54:496.
  • LEVY G: Pharmacokinetics of salicylate elimination in man. J. Pharm. Sci. (1965) 54:959-967.
  • TUCHMAN M, MCCANN MT, JOHNSON PE, LEMIEUX B: Screening newborns for multiple organic acidurias in dried filter paper urine samples: method development. Pediatric Res. (1991) 30:315-321.
  • EATON S, BARTLETT K, POURFARZAM M: Mammalian mitochondrial β-oxidation. Biochem. J. (1996) 320:345-357.
  • LI J, NORWOOD DL, MAO L-F, SCHULTZ H: Mitochondrial metabolism of valproic acid. Biochemistry (1991) 30:388-394.
  • SILVA MFB, RUITER JPN, IJLST L et al.: Synthesis and intramitochondrial levels of valproyl-coenzyme A metabolites. Anal. Biochem. (2001) 290:60-67.
  • FROMENTY B, PESSAYRE D: Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol. Ther. (1995) 67:101-154.
  • BELAY ED, BRESEE JS, HOLMAN RC, KHAN AS, SHAHRIARI A, SCHONBERGER LB: Reye’s syndrome in the Unites States from 1981 through 1997. N. Engl. J. Med. (1999) 340:1377-1382.
  • GLASGOW JFT, MIDDLETON B: Reye syndrome – insights on causation and prognosis. Arch. Dis. Child. (2001) 85:351-353.
  • BOELSTERLI UA: Xenobiotic acyl glucuronides and acyl CoA thioesters as protein-reactive metabolites with the potential to cause idiosyncratic drug reactions. Curr. Drug Metab. (2002) 3:439-450.
  • CHOW EL, CHERRY JD: Reassessing Reye syndrome. Arch. Pediatr. Adolesc. Med. (2003) 157:1241-1242.
  • CALDWELL J: Conjugation of xenobiotic carboxylic acids. In: Metabolic basis of detoxication. Metabolism of functional groups. Jakoby B, Bend R, Caldwell J (Eds), Academic Press, New York, USA (1982):271-289.
  • TANG W, ABBOTT FS: A comparative investigation of 2-propyl-4-pentenoic acid (4-ene VPA) and it’s α-fluorinated analogue: Phase II metabolism and pharmacokinetics. Drug Metab. Dispos. (1997) 25:219-227.
  • GRILLO MP, CHIELLINI G, TONELLI M, BENET LZ: Effect of α-fluorination of valproic acid on valproyl-S-acyl-CoA formation in vivo in rats. Drug Metab. Dispos. (2001) 29:1210-1215.
  • SOLTYSIAK RM, MATSUURA F, BLOOMER D, SWEELEY CC: d, l-alpha-fluoropalmitic acid inhibits sphingosine base formation and accumulates in membrane lipids of cultured mammalian cells. Biochim. Biophys. Acta. (1984) 792:214-226.
  • KUSLIKIS BI, VANDEN HEUVEL JP, PETERSON RE: Lack of evidence for perfluorodecanoyl or perfluorooctanoyl-coenzyme A formation in male and female rats. J. Biochem. Toxicol. (1992) 7:25-29.
  • VIDA, version 2.1.2; Openeye Scientific Software, Santa Fe, NM, USA (2006).
  • SIDENIUS U, SKONBERG C, OLSEN J, HANSEN SH: In vitro reactivity of carboxylic acid-CoA thioesters with glutathione. Chem. Res. Toxicol. (2004) 17:75-81.
  • HAMOSH A, MAHER J, BELLUS G, RASMUSSEN S, JOHNSTON MV: Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia. J. Pediatr. (1998) 132:709-713.
  • BATSHAW ML, MACARTHUR RB, TUCHMAN M: Alternative pathway therapy for urea cycle disorders: twenty years later. J. Pediatr. (2001) 138:S46-S55.
  • VAN HOVE JLK, VANDE KERCKHOVE K et al.: Benzoate treatment and the glycine index in nonketotic hyperglycinaemia. J. Inhert. Metab. Dis. (2005) 28:651-663.
  • FURUYA KN, DURIE PR, ROBERTS EA et al.: Glycine conjugation of para-aminobenzoic acid (PABA): a quantitative test of liver function. Clin. Biochem. (1995) 28:531-540.
  • LEBEL S, NAKAMACHI Y, HEMMING A, VERJEE Z, PHILLIPS MJ, FURUYA KN: Glycine conjugation of para-aminobenzoic acid (PABA): a pilot study of a novel prognostic test in acute liver failure in children. J. Pediatr. Gastroenterol. Nutr. (2003) 36:62-71.
  • MAWAL Y, PARADIS K, QURESHI IA: Developmental profile of mitochondrial glycine N-acyltransferase in human liver. J. Pediatr. (1997) 130:1003-1007.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.